Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma

Current treatments for cholangiocarcinoma (CCA) are largely unsuccessful due to late diagnosis at advanced stage, leading to high mortality rate. Consequently, improved therapeutic approaches are urgently needed. Chimeric antigen receptor (CAR) T cell therapy is a newly potential therapy that can re...

Descripción completa

Detalles Bibliográficos
Autores principales: Supimon, Kamonlapat, Sangsuwannukul, Thanich, Sujjitjoon, Jatuporn, Phanthaphol, Nattaporn, Chieochansin, Thaweesak, Poungvarin, Naravat, Wongkham, Sopit, Junking, Mutita, Yenchitsomanus, Pa-thai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973425/
https://www.ncbi.nlm.nih.gov/pubmed/33737613
http://dx.doi.org/10.1038/s41598-021-85747-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973425/
https://www.ncbi.nlm.nih.gov/pubmed/33737613
http://dx.doi.org/10.1038/s41598-021-85747-9

Ejemplares similares